09-12-2021 | Non-small-cell lung cancer | Video
RET fusion-positive NSCLC: delivering targeted treatment
Speakers: Stephen Liu, Melina Marmarelis and Vivek Subbiah
Stephen Liu leads Melina Marmarelis and Vivek Subbiah in a discussion on the care of patients with RET fusion-positive NSCLC in light of the ARROW trial of pralsetinib.